Acadia Pharmaceuticals

Acadia’s schizophrenia drug trial fails to meet primary endpoint
Clinical Trials Arena
Tue, 03/12/24 - 11:20 am
Acadia Pharmaceuticals
clinical trials
schizophrenia
pimavanserin
The Neuropsychiatric Pipeline: 10 Late-Stage Therapies to Watch
BioSpace
Mon, 08/14/23 - 11:23 am
depression
Biogen
SAGE Therapeutics
zuranolone
Intra-Cellular Therapies
lumateperone
Alto Neuroscience
ALTO-100
schizophrenia
Karuna Therapeutics
KarXT
Cerevel Therapeutics
emraclidine
Acadia Pharmaceuticals
pimavanserin
Axesome Therapeutics
AXS-05
Alzheimer's agitation
NRx
NRX-101
bipolar disorder
Biohaven
troriluzole
OCD
VistaGen
fasedienol
social anxiety
Why These 2 Biotech Stocks Made Big Moves Late Thursday
Motley Fool
Thu, 07/13/23 - 08:48 pm
Acadia Pharmaceuticals
Theseus Pharmaceuticals
Acadia gives once-rejected Prader-Willi drug a second chance
BioPharma Dive
Wed, 06/14/23 - 06:40 pm
Acadia Pharmaceuticals
Prader-Willi Syndrome
clinical trials
ACP-101
Carbetocin
Acadia wins first FDA approval for Rett syndrome drug
Endpoints
Mon, 03/13/23 - 10:04 am
Acadia Pharmaceuticals
FDA
Daybue
Rett Syndrome
Go or no go? Vaccines and neurology up for discussion
EP Vantage
Tue, 02/28/23 - 11:05 am
FDA
Acadia Pharmaceuticals
Apellis Pharmaceuticals
AstraZeneca
Biogen
Biomarin
Cidara Therapeutics
Emergent BioSolutions
GSK
Incyte
Ionis Pharmaceuticals
Melinta Therapeutics
Mundipharma
Novartis
Pfizer
Pharming
Regeneron
Roche
vaccines
RSV
ALS
COVID-19
5 FDA decisions to watch in the first quarter
BioPharma Dive
Mon, 01/9/23 - 10:27 am
FDA
Eli Lilly
donanemab
Alzheimer's disease
Menareni
Elacestrant
breast cancer
Biomarin
Roctavian
hemophilia A
Acadia Pharmaceuticals
trofinetide
Rett Syndrome
Gilead Sciences
Trodelvy
Biotech’s key upcoming clinical results
EP Vantage
Tue, 12/20/22 - 10:27 am
clinical trials
Acadia Pharmaceuticals
Argenx
Arrowhead Pharmaceuticals
Biomarin
BioNTech
Daiichi Sankyo
Day One
EQRx
Fate Therapeutics
FibroGen
Gilead Sciences
Idorsia
Immunogen
Intellia Therapeutics
Karuna Therapeutics
Moderna Therapeutics
Regeneron
Roche
Travere Therapeutics
Vaxcyte
Acadia hits another Nuplazid roadblock as the FDA doles out CRL and recommends another trial
Endpoints
Fri, 08/5/22 - 10:51 am
Acadia Pharmaceuticals
Nuplazid
FDA
complete response letter
Alzheimer's disease psychosis
Acadia's Alzheimer’s Drug Voted Down by FDA Advisory Committee
BioSpace
Mon, 06/20/22 - 10:30 am
Acadia Pharmaceuticals
Nuplazid
FDA
Alzheimer's disease
A year after CRL, Acadia is going back to bat for Nuplazid at the FDA
Endpoints
Mon, 05/2/22 - 06:15 pm
Acadia Pharmaceuticals
FDA
Nuplazid
Alzheimer's disease psychosis
Late-stage pain pipeline refuses to swell
EP Vantage
Tue, 04/26/22 - 10:29 pm
painkillers
Vertanical
Teva Pharmaceutical
Regeneron
Ampio Pharmaceuticals
Biogen
Eli Lilly
Vertex Pharmaceuticals
AstraZeneca
Acadia Pharmaceuticals
Acadia's prized pain drug from $52M buyout flops its first test
Endpoints
Tue, 04/19/22 - 10:57 am
Acadia Pharmaceuticals
CerSci Therapeutics
M&A
ACP-044
non-opioid pain treatments
FDA panel to review once-rejected Acadia drug for psychosis
BioPharma Dive
Thu, 03/10/22 - 10:23 pm
Acadia Pharmaceuticals
FDA
Nuplazid
Alzheimer's disease psychosis
Acadia slims Nuplazid label expansion bid in hopes of clinching Alzheimer's dementia nod without extra studies
Fierce Pharma
Tue, 12/21/21 - 10:18 am
Acadia Pharmaceuticals
Nuplazid
dementia
Alzheimer's disease psychosis
Three Pharma Companies Seek to Address FDA Rejections
BioSpace
Wed, 11/17/21 - 11:50 pm
FDA
Iterum
sulopenem
Eton Pharmaceuticals
Acadia Pharmaceuticals
Nuplazid
Big pharma leads the way in stock market resurgence
EP Vantage
Wed, 07/7/21 - 10:49 am
Big Pharma
pharma stocks
Acadia Pharmaceuticals
AstraZeneca
Biogen
Eli Lilly
GSK
Merck
Moderna Therapeutics
Novartis
Sanofi
Provention Bio
FDA rejects Acadia’s bid for Nuplazid approval in dementia-related psychosis
MedCity News
Mon, 04/5/21 - 02:37 pm
Acadia Pharmaceuticals
Nuplazid
dementia-related psychosis
FDA
5 FDA approval decisions to watch in the second quarter
BioPharma Dive
Mon, 03/29/21 - 11:16 pm
FDA
Biogen
aducanumab
Acadia Pharmaceuticals
pimavanserin
AstraZeneca
vaccines
COVID-19
Sanofi
Avalglucosidase alfa
Pfizer
pneumococcal disease
Acadia's surprise Nuplazid snag—and subsequent cold shoulder at FDA—beg more questions than answers
Fierce Pharma
Wed, 03/10/21 - 11:17 am
Acadia Pharmaceuticals
FDA
Nuplazid
Parkinson's Disease Psychosis

Pages